Gadget Island, Inc. is recalling approximately 1,485 units of various male enhancement capsules, including RHINO 7 Platinum 5000, PapaZen 3300, FIFTY SHADES 6000, and grande X 5800. These products, sold in 1-capsule packets, were found to contain undeclared active pharmaceutical ingredients including sildenafil, desmethyl carbodenafil, and tadalafil. These are the active ingredients in FDA-approved prescription drugs used to treat erectile dysfunction, but they are not listed on the product labels. Consumers should contact their healthcare provider or pharmacist for guidance regarding these products and return any unused portions to the place of purchase for a refund.
These undeclared ingredients can pose a serious health risk because they may interact with nitrates found in some prescription drugs (such as nitroglycerin) and can lower blood pressure to dangerous or life-threatening levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates and are at higher risk of serious adverse effects.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.